Though nine million kids across the U.S. get their health insurance through CHIP, Congress let the program expire Sept. 30. Since then, states have been burning through the cash that remains in their CHIP accounts, and parents, doctors and state officials are wondering if Congress will save what has traditionally been a popular program with strong bipartisan support
Quick Read
Report: Half of US Medical Care Delivered at Emergency RoomsOctober 18, 2017 |
Researchers at the University of Maryland School of Medicine were shocked to find that nearly half of all medical care in the United States is delivered at hospital emergency departments
Quick Read
The Collapse of Trumpcare and the Rise of the Single PayerOctober 17, 2017 |
Adam Gaffney and our Zackary Berger write, “Single payer bills signal a new era in American healthcare politics”
Quick Read
The drug, Mavyret, is the first to be approved by the Food and Drug Administration that can cure all six genetic types of hepatitis C in about two months in patients who haven’t previously been treated. Other approved drugs generally require 12 weeks to treat the disease and often aren’t effective for all types of hepatitis C
Quick Read
Doctors: NoSeptember 21, 2017 |
Today, America’s major physician organizations are recommending something, strongly and in unison: The latest health-care bill, known as Graham-Cassidy, would do harm to the country and should be defeated.
Quick Read
A Start-Up Suggests a Fix to the Health Care MorassAugust 16, 2017 |
If you watched the drama in Washington last month, you may have come away with the impression that the American health care system is a hopeless mess. So it is surprising that across the continent from Washington, investors and technology entrepreneurs in Silicon Valley see the American health care system as the next great market for reform
Quick Read
Nolan and Jack Willis and just 10 other boys took part in a clinical trial that led to the approval last fall of the very first drug to treat their rare, deadly muscle disease. Now the Willis boys are again test cases as a different type of medical question comes to the fore: whether insurers will cover the controversial drug, Exondys 51, which can cost more than $1 million a year even though it’s still unclear if it works
Quick Read
Sites such as GoFundMe and YouCaring are poised for a wave of medical appeals if Trumpcare leaves millions uninsured, and even if it doesn’t
Quick Read
